Publications
Main content start
Site content
- Vilcant, V., Ceron, C., Verma, G., Zeltser, R., & Makaryus, A. (2022). Inclusion of Under-Represented Racial and Ethnic Groups in Cardiovascular Clinical Trials. Elsevier B.V., 31, 1263-1268.
- Lie, M. S., McParlin, C., McColl, E., Graham, R., & Robson, S. (2022). Emesis in pregnancy - a qualitative study on trial recruitment failure from the EMPOWER internal pilot. BioMed Central Ltd., 8.
- Masters, J., Cook, J., Anderson, G., Nucci, G., Colzi, A., Hellio, M., & Corrigan, B. (2022). Ensuring diversity in clinical trials: The role of clinical pharmacology. Elsevier Inc., 118.
- Brandon, T., Jecca, S., Brannon, W., Fatima, R., & Mark, C. (2022). Race-ethnicity reporting and representation in US clinical trials: A cohort study. Elsevier, 11.
- Zhi, Z., Yaotiao, D., Jie, L., Keyi, Y., Hu, P., & Yu, J. (2022). Chinese Cancer Patients’ Attitudes Toward Psychotherapy and Their Willingness to Participate in Clinical Trials of Psychotherapy. SAGE Publishing, 29.
- Singer, R., Crooks, N., Abboud, S., & Patil, C. (2022). Engaging Vulnerable Populations in Community-based Participatory Research: Lessons Learned. 16, 227-234.
- Nicholas, S., & Cervantes, L. (2022). Health Care Equity and Justice Scorecard To Increase Diversity in Clinical Trial Recruitment and Retention.
- Le, D., Ozbeki, H., Salazar, S., Berl, M., Turner, M., & Price, O. (2022). Improving African American women’s engagement in clinical research: A systematic review of barriers to participation in clinical trials. Elsevier Inc., 114, 324-339.
- Adrissi, J., & Fleisher, J. (2022). Moving the Dial Toward Equity in Parkinson’s Disease Clinical Research: a Review of Current Literature and Future Directions in Diversifying PD Clinical Trial Participation. Springer US, 1-9.
- Nicum, S., & Blagden, S. (2022). PARPs: All for One and One for All? Enhancing Diversity in Clinical Trials. 28, 2201-2203.
- Ferguson, J., Vetos, D., Ho, B., Aziz, M., Lee, W., Mohyuddin, G., & Prouty, M. (2022). Trends in diversity of participants in dermatology clinical trials over time: A systematic review. Elsevier Inc., 86, 1403-1405.
- Zanfardino, S., Mazziotto, V., & Bodas, P. (2022). Black Americans’ willingness to participate in pediatric sickle cell clinical trials: A retrospective, systematic review. Wiley Subscription Services, Inc., 69.
- Kelsey, M., Patrick-Lake, B., Abdulai, R., Broedl, U., Brown, A., Cohn, E., Curtis, L., Komelasky, C., Mbagwu, M., Mensah, G., Mentz, R., Nyaku, A., Omokaro, S., Sewards, J., Whitlock, K., Zhang, X., & Bloomfield, G. (2022). Inclusion and diversity in clinical trials: Actionable steps to drive lasting change. Elsevier Inc., 116.
- Sanchez, A., Ison, J., Hemley, H., Willis, A., Siddiqi, B., Macklin, E., Ulysse, C., Reynolds, M., Schwarzschild, M., & Jackson, J. (2022). Designing the Fostering Inclusivity in Research Engagement for Underrepresented Populations in Parkinson’s Disease study. Elsevier B.V., 115.
- Scarinci, I., Hansen, B., Green, L., Sodeke, S., Price-Haywood, E., & Kim, Y. (2022). Willingness to participate in various nontherapeutic cancer research activities among urban and rural African American and Latinx healthy volunteers.
- Wei, S., Le, N., Zhu, J., Breathett, K., Greene, S., Mamas, M., Zannad, F., & Van Spall, H. (2022). Factors Associated With Racial and Ethnic Diversity Among Heart Failure Trial Participants: A Systematic Bibliometric Review. 15.
- Ginossar, T., Fuentes, C., & Oetzel, J. (2022). Understanding Willingness to Participate in Cancer Clinical Trials Among Patients and Caregivers Attending a Minority-Serving Academic Cancer Center. Springer, 37, 179.
- Li, M., Kim, H., Sereika, S., Nissley, T., & Lingler, J. (2022). Willingness to Participate in Clinical Research Among Individuals With Cognitive Impairment. Slack, Inc., 1.
- Arring, N., Aduse-Poku, L., Jiagge, E., Saylor, K., White-Perkins, D., Israel, B., Walker, E., Hinebaugh, A., Harb, R., DeWitt, J., Molnar, M., Wilson-Powers, E., & Brush, B. (2022). A Scoping Review of Strategies to Increase Black Enrollment and Retention in Cancer Clinical Trials.
- Suzanne, M. (2022). Amending Federal Regulations to Counteract Language Barriers in the Informed Consent Process. Columbia University Libraries, 8.